Allurion Technologies CEO Resigns; COO to Oversee Operations

What Happened

• Allurion Technologies, Inc. (filed 8-K on July 23, 2026) announced that Shantanu K. Gaur, M.D., resigned as Chief Executive Officer and as a member of the board effective immediately on July 17, 2026. The filing states the resignation was not due to any disagreement with the company or the board.
• The board has not named an interim or permanent CEO. Chief Operating Officer Ojas Buch will oversee the company’s day-to-day operations and take on certain responsibilities previously performed by Dr. Gaur. Mr. Buch’s title and compensation were not changed in connection with these responsibilities.

Key Details

• Effective date of resignation: July 17, 2026; 8-K filed: July 23, 2026.
• Resignation explicitly “not the result of any disagreement” with company operations, policies, or practices.
• No interim or permanent CEO appointed by the board as of the filing.
• COO Ojas Buch to manage daily operations; no change to his title or pay.

Why It Matters

• A CEO departure is a material leadership change that can affect strategy, operations and investor confidence. The lack of a named successor means investors should watch for further disclosures on CEO appointment, governance decisions, or any shifts in strategy.
• The company has appointed the COO to maintain continuity in daily operations, and the filing notes no immediate compensation changes, which may limit short-term disruption. Investors should monitor subsequent SEC filings and company announcements for updates on leadership, succession plans, and any operational impact.